clinical trialsAlexion Pharmaceuticals2018-03-19 08:24Read 91
Alexion Pharmaceuticals' investigational long-acting C5 complement inhibitor, ALXN1210, has succeeded in the pivotal phase 3 study of patients with rare blood disorder, paroxysmal nocturnal hemoglobinuria (PNH).
TrendMerck2018-03-09 09:48Read 84
Merck & Co likes the data coming out of trials combining its immuno-oncology drug Keytruda with Eisai’s Lenvima - and has signed a big deal to bind the two products closer together.
TrendFierceBiotech2018-03-09 09:44Read 70
Israeli biotech VBL Therapeutics has joined a long and depressing line of companies that have failed to move the needle in a test against a form of aggressive brain tumor.
clinical trialsNovartis 2018-03-09 09:39Read 113
Novartis said that it will use Science 37's Network Oriented Research Assistant (NORA) technology in up to 10 clinical trials over the next three years.
R&DCold Spring Harbour 2018-03-09 09:39Read 50
Scientists at Cold Spring Harbor Laboratory (CSHL) have discovered a way to rein in an overactive protein that drives some aggressive leukaemias.
TrendBoehringer Ingelheim2018-03-09 08:26Read 35
Boehringer Ingelheim and Eli Lilly have unveiled plans to expand their clinical trial program for Jardiance in chronic heart failure with the EMPERIAL clinical trials.
Trendworldpharmanews2018-03-09 08:18Read 32
Approximately one sixth of clinical trials registered on both ClinicalTrials.gov and the EU Clinical Trials Register (EUCTR) have discrepancies in their completion status, according to a study published March 7, 2018 in the open-access journal PLOS ONE by Jessica Fleminger and Ben Goldacre from the University of Oxford, UK.
TrendDana-farber2018-03-07 09:08Read 38
A sizable percentage of elderly patients with blood-related cancers such as leukemia and multiple myeloma are apt to show signs of diminished cognitive functioning, a decline that may impact their survival, a new study by investigators at Dana-Farber Cancer Institute and Brigham and Women's Hospital (BWH) indicates.
R&DUniversity of Extremadura2018-03-07 08:57Read 31
Cancer stem cells possess the capacity to adopt highly undifferentiated states, characteristic of pluripotent cells, which very possibly contribute to the progression and maintenance of the different cells that form the tumour, in the same way that a healthy stem cell can give rise to different cell phenotypes.
TrendDermira 2018-03-07 08:56Read 33
The US biotech lost two-thirds of its share value after the news broke